Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
1.
Minerva Urol Nefrol ; 53(2): 57-9, 2001 Jun.
Article de Italien | MEDLINE | ID: mdl-11455311

RÉSUMÉ

BACKGROUND: Elevated serum levels of homocysteine have increasingly been associated as a risk factor of cardiovascular disease. Recent reports demonstrated that supplements of folates, vitamin B12 (B12) and vitamin B6 (B6) are effective in correcting serum Hcy levels in hemodialysed patients. AIM: to assess the effectiveness of oral supplements of folates, B12 and B6, in order to reduce serum Hcy levels in our cohort of hemodialysed patients. METHODS: Sixty-one hemodialysed patients have been enrolled in the study (age 68+/-13 years; hemodialysis 62+/-42 months). Oral supplements of calcium folinate (30 mg 3 times a week), B12 (500 mg 3 times a week) and B6 (200 mg 3 times a week) were administered at the end of each hemodialysis session. Serum levels of Hcy, folic acid and B12 were tested at the beginning of the study and at 2 month intervals. RESULTS: After 5 months of follow-up, serum levels of Hcy were normalised in 19% of our patients and in total 70% of them showed a reduction >8% when compared with the basal Hcy levels. No side effects related to folates, B12 or B6 supplementation were observed. CONCLUSIONS: Oral supplements of folates, B12 and B6 are a safe and effective treatment of hyperhomocysteinemia in hemodialysed patients.


Sujet(s)
Compléments alimentaires , Acide folique/administration et posologie , Dialyse rénale , Vitamine B12/administration et posologie , Vitamine B6/administration et posologie , Administration par voie orale , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Études de suivi , Humains , Mâle , Adulte d'âge moyen , Facteurs temps
2.
Minerva Urol Nefrol ; 50(3): 179-83, 1998 Sep.
Article de Italien | MEDLINE | ID: mdl-9842219

RÉSUMÉ

BACKGROUND AND AIMS: This study reports a retrospective evaluation of the predominance of infection in 67 dual lumen central venous catheters (CVC), 35 of which were positioned in the femoral vein by the nephrological team and 32 in the subclavian vein by anesthetists. METHODS: The microorganisms responsible for infection, the prevalence of clinically symptomatic infections, the relationship between CVC-correlated infection and the time the catheter remained inserted were evaluated, together with a comparison between the two different insertion sites. RESULTS: Culture tests, performed using Maki's semiquantitative technique, gave positive results in 16/67 (23.8%) cases. The main pathogenic agents found were Staphylococcus epidermidis (37.5%) and Staphylococcus aureus (31.2%). In 3/16 cases (18.78%) infections were clinically symptomatic. The mean permanence of CVC with positive cultures was not statistically different to the mean permanence of CVC with negative cultures (22.44 +/- 13.48 vs 18.38 +/- 17.76). The microorganisms isolated on femoral and subclavian catheters showed a comparable distribution and the prevalence of infection was not statistically different in the two insertion sites. CONCLUSIONS: In conclusion, in the absence of infection, the authors tend to keep working catheters in the site, thus avoiding repeated invasive manoeuvres for replacement and/or repositioning, whereas in the presence of suspected systemic infection they feel it is more prudent to remove the CVC without waiting for the results of the hemoculture, starting first empiric and then specific antibiotic treatment on the basis of the antibiogram.


Sujet(s)
Infections bactériennes/microbiologie , Cathétérisme veineux central/effets indésirables , Cathétérisme veineux central/instrumentation , Humains , Études rétrospectives
3.
Minerva Stomatol ; 45(10): 465-70, 1996 Oct.
Article de Italien | MEDLINE | ID: mdl-9026691

RÉSUMÉ

Brown tumour is one of the forms in which fibrous-cystic osteitis, which represents the terminal stage of the bone remodelling processes during primary or secondary hyperparathyroidism, is manifested. For years brown tumour was regarded as a typical lesion of primary hyperparathyroidism, but cases of brown tumours in patients with hyperparathyroidism secondary to renal failure were increasingly often reported in the literature. From an epidemiological point of view, the frequency of brown tumours in patients with renal insufficiency is extremely variable, as is the bone site affected. Several bone segments can be affected at once, but the ethmoid and frontal sinus are rarely reported. Symptoms are caused by the considerable dimensions of the brown tumour and its localisation: in the jawbones it may present sometimes painful, hard and clearly palpable swellings; if large, the tumour may deform the appearance of the bone segments affected or alter the function of the masticatory apparatus. In other cases, there is a complete absence of clinical symptoms and diagnosis may be totally coincidental during the radiological examinations. In histological terms, brown tumours are made up by a cell population consisting of rounded or spindle-like mononucleate elements, mixed with a certain number of plurinucleate giant cells, resembling osteoclastic cells, among which recent haemorrhagic infiltrates and hemosiderin deposits (hence the brown colour) are often found. The aim of this study was to report three cases from a population of 107 patients undergoing haemodialysis at the Turin University Centre. In conclusion, the localisation of maxillary brown tumours appears to prefer a young, female population; brown tumours are rarely an early sign of hyperparathyroidism in haemodialysis patients, but they often appear in conditions of advanced hyperparathyroidism which have escaped medical control either owing to unsuitable therapy or scant patient compliance; they are rapidly evolving lesions whose regression may be very slow or not occur even after total parathyroidectomy; the severity of the lesion caused by a brown tumour may lead to evident osteolysis in the maxillofacial district, thus suggesting the need for early and regular radiological screening; in the event of lesions which are already present, from the authors' point of view, the choice of treatment must be oriented towards parathyroidectomy.


Sujet(s)
Granulome à cellules géantes/étiologie , Maladies de la mâchoire/étiologie , Adulte , Biopsie , Femelle , Granulome à cellules géantes/diagnostic , Granulome à cellules géantes/anatomopathologie , Humains , Hyperparathyroïdie secondaire/complications , Hyperparathyroïdie secondaire/anatomopathologie , Mâchoire/imagerie diagnostique , Mâchoire/anatomopathologie , Maladies de la mâchoire/diagnostic , Maladies de la mâchoire/anatomopathologie , Ostéite fibrokystique/complications , Ostéite fibrokystique/anatomopathologie , Radiographie , Dialyse rénale
4.
Ren Fail ; 18(4): 567-74, 1996 Jul.
Article de Anglais | MEDLINE | ID: mdl-8875681

RÉSUMÉ

Scleroderma renal crisis (SRC) was known as a rare and catastrophic syndrome responsible for acute renal failure (ARF) in a context of widespread microvascular disease occurring in progressive systemic sclerosis (PSS). Following pathogenetic hypoteses, angiotensin converting enzyme (ACE) inhibitors, plasma infusions (PI), and plasma-exchange (PE) have been employed in SRC with favorable results. Our purpose was to verify whether these therapies have consistently changed the fatal prognosis of SRC, even in our experience. In the last 10 years, SRC was diagnosed in eight patients (all eight with histologic data). The first five cases were treated with steroids, antihypertensive-cocktail, and PI: all five died, two within 48 hours, three after 10, 15, and 300 days, respectively. Three other patients were treated with ACE inhibitors, PI, and PE: all three died after 1, 9, and 12 months of HD. Clinical-histological correlations showed a strong relationship between the extent of glomerular involvement and the degree of renal failure, while arterial lesions seem to be more related to the past history of PSS, independently from the previous existence of hypertension. We conclude that "true" SRC diagnosed by restrictive criteria is still a rare life-threatening syndrome, and, unfortunately, no clear predictive biochemical or clinical signs could be identified; vascular renal involvement correlates to the duration of PSS independently of previous clinical evidence of renal failure or hypertension; a glomerular pattern similar to that reported for hemolytic-uremic syndrome (HUS)/thrombotic thrombocytopenic purpura (TTP) syndrome is directly related to the degree of acute renal involvement; SRC may occur even in the absence of hypertension, mainly if cardiomyopathy is present: in our experience. ACE inhibitors and plasma therapies have changed the short-time prognosis of SRC, but they may be unable to provide recovery from dialysis and do not avoid further evolution of extrarenal PSS exiting in late death.


Sujet(s)
Défaillance rénale chronique/étiologie , Sclérodermie systémique/complications , Adulte , Inhibiteurs de l'enzyme de conversion de l'angiotensine/usage thérapeutique , Biopsie , Évolution de la maladie , Femelle , Études de suivi , Humains , Hypertension rénale/complications , Hypertension rénale/physiopathologie , Hypertension rénale/thérapie , Défaillance rénale chronique/anatomopathologie , Défaillance rénale chronique/thérapie , Mâle , Adulte d'âge moyen , Échange plasmatique , Pronostic , Dialyse rénale , Sclérodermie systémique/anatomopathologie , Sclérodermie systémique/thérapie , Syndrome
5.
Minerva Urol Nefrol ; 44(4): 261-4, 1992.
Article de Italien | MEDLINE | ID: mdl-1299007

RÉSUMÉ

Doppler sonography is nowadays considered as a "first step" tool for diagnosis of vascular complications in kidney transplantation. Quite recently, it has been sometimes considered useful and effective investigation in order to obtain information about parenchymal dysfunctional pathologies, particularly about acute rejection. This has been obtained by studying the variation of resistive indexes. The goal of the following investigation was compare Doppler sonography data and histological examination in 50 kidney transplanted recipients in whom the renal biopsy was performed on a clinical basis. In the Authors' experience. Doppler sonography and study of the resistive index does not offer any reliable help in differentiating acute rejection from cyclosporine A toxicity.


Sujet(s)
Biopsie , Transplantation rénale , Complications postopératoires/diagnostic , Ciclosporine/effets indésirables , Diagnostic différentiel , Études d'évaluation comme sujet , Rejet du greffon/complications , Rejet du greffon/imagerie diagnostique , Rejet du greffon/anatomopathologie , Humains , Rein/imagerie diagnostique , Rein/anatomopathologie , Maladies du rein/induit chimiquement , Maladies du rein/imagerie diagnostique , Maladies du rein/anatomopathologie , Complications postopératoires/étiologie , Échographie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE